RA
SRTA

Royce & Associates’s Strata Critical Medical Inc SRTA Stock Holding History

Royce & Associates’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5M Buy
3,132,933
+316,561
+11% +$1.67M 0.13% 255
2026
Q1 		$11.8M Buy
2,816,372
+1,072,043
+61% +$5.16M 0.12% 279
2025
Q4 		$8.39M Buy
1,744,329
+703,086
+68% +$3.4M 0.09% 361
2025
Q3 		$5.27M Buy
1,041,243
+683,138
+191% +$3.02M 0.05% 461
2025
Q2 		$1.44M Sell
358,105
-134,038
-27% -$436K 0.01% 638
2025
Q1 		$1.34M Buy
492,143
+143
+0% +$513 0.01% 643
2024
Q4 		$2.09M Buy
+492,000
New +$1.87M 0.02% 625

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Royce & Associates's SRTA Position: Q2 2026 in Review

Royce & Associates increased its Strata Critical Medical Inc (SRTA) stake by 11% in Q2 2026, buying an estimated $1.67M and bringing the position to 3,132,933 shares worth $16.5M. The position accounts for 0.13% of the portfolio, ranked #255.

Royce & Associates first reported a position in SRTA in Q4 2024 and has held it in 7 quarters since. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Royce & Associates held 3,132,933 shares of Strata Critical Medical Inc worth $16.5M as of Q2 2026.
  • Royce & Associates bought 316,561 Strata Critical Medical Inc shares in Q2 2026, an estimated $1.67M.
  • Strata Critical Medical Inc made up 0.13% of Royce & Associates's portfolio in Q2 2026, its #255 holding.
  • Royce & Associates first reported a position in Strata Critical Medical Inc in Q4 2024 and has held it in 7 quarters since.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.